Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF InhibitionHélène Salmon, Miriam Mérad, Juliana Idoyaga et al.|Immunity|2016Cited by 1.2k
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, João B. Xavier, Ying Taur et al.|New England Journal of Medicine|2020Cited by 739